Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,854
Closed -$64K 131
2019
Q4
$64K Hold
1,854
0.04% 94
2019
Q3
$64K Hold
1,854
0.04% 94
2019
Q2
$76K Sell
1,854
-317
-15% -$12.6K 0.04% 89
2019
Q1
$87K Sell
2,171
-18
-0.8% -$721 0.05% 90
2018
Q4
$90K Sell
2,189
-63,762
-97% -$2.65M 0.05% 93
2018
Q3
$2.76M Sell
65,951
-355,936
-84% -$13.7M 0.45% 54
2018
Q2
$14.6M Buy
421,887
+63,762
+18% +$2.18M 1.97% 12
2018
Q1
$12M Hold
358,125
5.61% 4
2017
Q4
$12.4M Hold
358,125
6.18% 4
2017
Q3
$12.1M Hold
358,125
6.36% 5
2017
Q2
$11.4M Hold
358,125
6.32% 5
2017
Q1
$11.6M Sell
358,125
-48,821
-12% -$1.54M 7.59% 5
2016
Q4
$12.6M Buy
406,946
+149
+0% +$4.55K 8.53% 4
2016
Q3
$13.1M Buy
406,797
+49,104
+14% +$1.64M 8.31% 4
2016
Q2
$11.9M Buy
357,693
+1,757
+0.5% +$56.1K 10.25% 4
2016
Q1
$10.1M Hold
355,936
9.62% 5
2015
Q4
$11M Hold
355,936
9.73% 5
2015
Q3
$10.6M Hold
355,936
9.62% 5
2015
Q2
$11.3M Buy
+355,936
New +$11.6M 10.38% 5

Other funds holding PFE

Ninety One's PFE Position: Q1 2020 in Review

Ninety One sold out of Pfizer (PFE) in Q1 2020, closing a stake of 1,854 shares — an estimated $64K sold.

Ninety One first reported a position in PFE in Q2 2015 and held it in 19 quarters. The position peaked at $14.6M in Q2 2018. 2,438 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Ninety One reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
  • Ninety One sold 1,854 Pfizer shares in Q1 2020, an estimated $64K.
  • Ninety One first reported a position in Pfizer in Q2 2015 and held it in 19 quarters.
  • Ninety One's Pfizer position peaked at $14.6M in Q2 2018.
  • 2,438 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Ninety One's 13F filing for Q1 2020, filed 13 May 2020.